Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling

European Journal of Neuroscience

Volumn 34, Issue 9, 2011, Pages 1378-1389

  Daigle, Tanya L ^a   Wetsel, William C ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

9 tetrahydrocannabinol; arrestin; CB1; Mitogen activated protein kinase; Mouse

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; BETA ARRESTIN 1; BETA ARRESTIN 2; CANNABINOID; DEXANABINOL; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRONABINOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; MOUSE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REWARD; SIGNAL TRANSDUCTION; WILD TYPE;

ANALGESICS, NON-NARCOTIC; ANIMALS; ARRESTINS; BODY TEMPERATURE; CANNABINOIDS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FREEZING REACTION, CATALEPTIC; FRONTAL LOBE; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PAIN PERCEPTION; PHOSPHORYLATION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL;

EID: 80055034638     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07874.x     Document Type: Article

References (46)

1. Andersson, M., Usiello, A., Borgkvist, A., Pozzi, L., Dominguez, C., Fienberg, A.A., Svenningsson, P., Fredholm, B.B., Borrelli, E., Greengard, P. & Fisone, G. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32kDa at the protein kinase A site in striatal projection neurons. J. Neurosci., 25, 8432-8438.
2. Beaulieu, J.M., Sotnikova, T.D., Gainetdinov, R.R. & Caron, M.G. (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J. Biol. Chem., 281, 32072-32080.
3. Bohn, L.M., Lefkowitz, R.J., Gainetdinov, R.R., Peppel, K., Caron, M.G. & Lin, F.T. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science, 286, 2495-2498.
4. Borgkvist, A., Marcellino, D., Fuxe, K., Greengard, P. & Fisone, G. (2008) Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology, 54, 31-35.
5. Bouaboula, M., Poinot-Chazel, C., Bourrie, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G. & Casellas, P. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J., 312, 637-641.
6. -/- mice. Behav. Pharmacol., 19, 298-307.
7. Conner, D.A., Mathier, M.A., Mortensen, R.M., Christe, M., Vatner, S.F., Seidman, C.E. & Seidman, J.G. (1997) beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res., 81, 1021-1026.
8. Daigle, T.L., Kearn, C.S. & Mackie, K. (2008a) Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology, 54, 36-44.
9. Daigle, T.L., Kwok, M.L. & Mackie, K. (2008b) Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J. Neurochem., 106, 70-82.
10. Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J. & Girault, J.A. (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci., 23, 2371-2382.
11. Drago, J., Gerfen, C.R., Lachowicz, J.E., Steiner, H., Hollon, T.R., Love, P.E., Ooi, G.T., Grinberg, A., Lee, E.J., Huang, S.P., Bartlett, P.F., Jose, P.A., Sibley, D.R. & Westphal, H. (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. USA, 91, 12564-12568.
12. Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L. & James, I. (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
13. French, E.D. (1997) delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett., 226, 159-162.
14. Gerdeman, G.L., Ronesi, J. & Lovinger, D.M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci., 5, 446-451.
15. Girault, J.A., Valjent, E., Caboche, J. & Herve, D. (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol., 7, 77-85.
16. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
17. Gomez Del Pulgar, T., De Ceballos, M.L., Guzman, M. & Velasco, G. (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem., 277, 36527-36533.
18. Hoffman, A.F. & Lupica, C.R. (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol., 85, 72-83.
19. Huang, C.C., Lo, S.W. & Hsu, K.S. (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol., 532, 731-748.
20. Jin, W., Brown, S., Roche, J.P., Hsieh, C., Celver, J.P., Kovoor, A., Chavkin, C. & Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci., 19, 3773-3780.
21. Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Hnasko, R., Ben-Jonathan, N., Grandy, D.K. & Low, M.J. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron, 19, 103-113.
22. Kouznetsova, M., Kelley, B., Shen, M. & Thayer, S.A. (2002) Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. Mol. Pharmacol., 61, 477-485.
23. Kreitzer, A.C. & Malenka, R.C. (2007) Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature, 445, 643-647.
24. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
25. Mackie, K. (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol., 168, 299-325.
26. Matyas, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U. & Freund, T.F. (2006) Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience, 137, 337-361.
27. Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell, 98, 427-436.
28. Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G., Wotjak, C.T., Lutz, B. & Marsicano, G. (2007) Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol., 5, e269.
29. Ozaita, A., Puighermanal, E. & Maldonado, R. (2007) Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem., 102, 1105-1114.
30. Ramsey, A.J., Laakso, A., Cyr, M., Sotnikova, T.D., Salahpour, A., Medvedev, I.O., Dykstra, L.A., Gainetdinov, R.R. & Caron, M.G. (2008) Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology, 33, 2701-2714.
31. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O.J. (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci., 21, 109-116.
32. Robbe, D., Kopf, M., Remaury, A., Bockaert, J. & Manzoni, O.J. (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA, 99, 8384-8388.
33. Rodriguez, J.J., Mackie, K. & Pickel, V.M. (2001) Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J. Neurosci., 21, 823-833.
34. Rubino, T., Vigano, D., Premoli, F., Castiglioni, C., Bianchessi, S., Zippel, R. & Parolaro, D. (2006) Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. Mol. Neurobiol., 33, 199-213.
35. Santini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J.A., Herve, D., Greengard, P. & Fisone, G. (2007) Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J. Neurosci., 27, 6995-7005.
36. van der Stelt, M. & Di Marzo, V. (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol., 480, 133-150.
37. Szabo, B., Dorner, L., Pfreundtner, C., Norenberg, W. & Starke, K. (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience, 85, 395-403.
38. Tanda, G., Pontieri, F.E. & Di Chiara, G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science, 276, 2048-2050.
39. Thomas, G.M. & Huganir, R.L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci., 5, 173-183.
40. Tzavara, E.T., Li, D.L., Moutsimilli, L., Bisogno, T., Di Marzo, V., Phebus, L.A., Nomikos, G.G. & Giros, B. (2006) Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol. Psychiatry, 59, 508-515.
41. Valjent, E., Corvol, J.C., Pages, C., Besson, M.J., Maldonado, R. & Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 20, 8701-8709.
42. Valjent, E., Pages, C., Rogard, M., Besson, M.J., Maldonado, R. & Caboche, J. (2001) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci., 14, 342-352.
43. Valjent, E., Pages, C., Herve, D., Girault, J.A. & Caboche, J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci., 19, 1826-1836.
44. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.C., Stipanovich, A., Caboche, J., Lombroso, P.J., Nairn, A.C., Greengard, P., Herve, D. & Girault, J.A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. USA, 102, 491-496.
45. Valjent, E., Corbille, A.G., Bertran-Gonzalez, J., Herve, D. & Girault, J.A. (2006a) Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc. Natl. Acad. Sci. USA, 103, 2932-2937.
46. Valjent, E., Corvol, J.C., Trzaskos, J.M., Girault, J.A. & Herve, D. (2006b) Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci., 7, 20.